Allarity Therapeutics, Inc. Payments of Financing Costs
Allarity Therapeutics, Inc. (ALLR) had Payments of Financing Costs of $10.00 million as of 2024-02-26, per its 10-Q filed 2024-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2024-05-14
- Allarity Therapeutics, Inc. payments of financing costs for the quarter ending 2023-06-30 was $378.00K.
- Allarity Therapeutics, Inc. payments of financing costs for the quarter ending 2023-03-31 was $9.00K.
| Period end | Payments of Financing Costs | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month |
|---|---|---|---|
| 2024-02-26 | $10.00M 10-Q · filed 2024-05-14 | ||
| 2023-06-30 | $378.00K 10-Q · filed 2023-08-14 | $387.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $9.00K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |